Evaluation of Treatment of Chronic HCV Patients in Chronic Kidney Disease Versus End Stage Renal Disease Patients
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
1. To asses curability of( Ombitasvir ,Paritaprevir,Ritonavir) in chronic HCV infected
patients in those with CKD versus ESRD in Assiut Hospital University .
2. Also assess duration of sustained viral response,treatment, relapse or failure of
therapy in CKD versus ESRD in Assiut Hospital.